Welcome To The Stem Cell Therapeutics HUB On AGORACOM

Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.

Free
Message: What am I missing

If investors came looking to buy 17+ million shares on the open market, the price wouldn't be at .16 for long. Share demand would push this much higher.

Share
New Message
Please login to post a reply